Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study.

Autor: Garrett N; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Discipline of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa., Reddy T; Biostatistics Research Unit, South African Medical Research Council (SAMRC), Durban, South Africa., Yende-Zuma N; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; Biostatistics Research Unit, South African Medical Research Council (SAMRC), Durban, South Africa., Takalani A; Hutchinson Center Research Institute of South Africa, Cape Town, South Africa., Woeber K; Grants, Innovation and Product Development Unit, SAMRC, Durban, South Africa., Bodenstein A; Right to Care, Johannesburg, Gauteng, South Africa., Jonas P; Right to Care, Johannesburg, Gauteng, South Africa., Engelbrecht I; Right to Care, Johannesburg, Gauteng, South Africa., Jassat W; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services (NHLS), Johannesburg, Gauteng, South Africa., Moultrie H; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases (NICD) of the National Health Laboratory Services (NHLS), Johannesburg, Gauteng, South Africa., Bradshaw D; Burden of Disease Research Unit, SAMRC, Tygerberg, South Africa., Seocharan I; Biostatistics Research Unit, South African Medical Research Council (SAMRC), Durban, South Africa., Odhiambo J; Hutchinson Center Research Institute of South Africa, Cape Town, South Africa., Khuto K; Hutchinson Center Research Institute of South Africa, Cape Town, South Africa., Richardson SI; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.; Centre for HIV and STIs, NICD of the NHLS, Johannesburg, Gauteng, South Africa., Omondi MA; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Nesamari R; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Keeton RS; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa., Riou C; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa., Moyo-Gwete T; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.; Centre for HIV and STIs, NICD of the NHLS, Johannesburg, Gauteng, South Africa., Innes C; Aurum Institute, Johannesburg, Gauteng, South Africa., Zwane Z; Aurum Institute, Johannesburg, Gauteng, South Africa., Mngadi K; Aurum Institute, Johannesburg, Gauteng, South Africa., Brumskine W; Aurum Institute, Johannesburg, Gauteng, South Africa., Naicker N; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Potloane D; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Badal-Faesen S; Clinical HIV Research Unit, Johannesburg, Gauteng, South Africa., Innes S; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Barnabas S; Family Centre for Research with Ubuntu, Tygerberg, South Africa., Lombaard J; Josha Research, Bloemfontein, South Africa., Gill K; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Nchabeleng M; Medunsa Clinical Research Unit, Sefako Makgatho Health Sciences University, Pretoria, South Africa., Snyman E; TASK Eden, George, South Africa., Petrick F; Mzansi Ethical Research Centre, Middelburg, South Africa., Spooner E; SAMRC Clinical Research Site, Durban South Africa., Naidoo L; SAMRC Clinical Research Site, Durban South Africa., Kalonji D; SAMRC Clinical Research Site, Durban South Africa., Naicker V; SAMRC Clinical Research Site, Durban South Africa., Singh N; SAMRC Clinical Research Site, Durban South Africa., Maboa R; Ndlovu Research Centre, Elandsdoorn, South Africa., Mda P; Nelson Mandela Academic Research Unit CRS, Mthatha, South Africa., Malan D; PHOENIX Pharma, Port Elizabeth, South Africa., Nana A; Perinatal HIV Research Unit, Johannesburg, Gauteng, South Africa., Malahleha M; Synergy Biomed Research Institute, East London, South Africa., Kotze P; Qhakaza Mbokodo Research Clinic, Ladysmith, South Africa., Allagappen JJ; Setshaba Research Centre, Soshanguve, South Africa., Diacon AH; TASK Central, Cape Town, South Africa., Kruger GM; Ubuntu Clinical Research, Krugersdorp, Gauteng, South Africa., Patel F; Wits RHI Research Institute, University of Witwatersrand, Johannesburg, Gauteng, South Africa., Moore PL; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa.; SAMRC Antibody Immunity Research Unit, School of Pathology, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.; Centre for HIV and STIs, NICD of the NHLS, Johannesburg, Gauteng, South Africa., Burgers WA; Institute of Infectious Disease and Molecular Medicine, Division of Medical Virology, Department of Pathology, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, University of Cape Town, Cape Town, South Africa., Anteyi K; Moderna Inc., Cambridge, Massachusetts, United States of America., Leav B; Moderna Inc., Cambridge, Massachusetts, United States of America., Bekker LG; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Gray GE; Office of the President and CEO, SAMRC, Cape Town, South Africa., Goga A; Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa.; HIV and other Infectious Diseases Research Unit, SAMRC, Durban, South Africa.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2024 Dec 05; Vol. 4 (12), pp. e0003260. Date of Electronic Publication: 2024 Dec 05 (Print Publication: 2024).

Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.

Autor: Bekker LG; The Desmond Tutu HIV Centre, Cape Town, South Africa; University of Cape Town, Cape Town, South Africa., Garrett N; Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa., Goga A; HIV Prevention Research Unit, Cape Town, South Africa; Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa., Fairall L; The Desmond Tutu HIV Centre, Cape Town, South Africa; King's Global Health Institute, King's College London, London, UK., Reddy T; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa., Yende-Zuma N; Nelson R Mandela School of Medicine, Centre for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban, South Africa., Kassanjee R; Centre of Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Cape Town, South Africa., Collie S; Discovery Health, Sandton, South Africa., Sanne I; Clinical HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Witwatersrand, South Africa; Right to Care, Houghton South Africa., Boulle A; Centre of Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Cape Town, South Africa; Western Cape Government Health, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Cape Town, South Africa., Seocharan I; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa., Engelbrecht I; Right to Care, Centurion, South Africa., Davies MA; Centre of Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Cape Town, South Africa; Western Cape Government: Health Centre for Infectious Disease Epidemiology and Research, Cape Town, South Africa., Champion J; Discovery Health, Sandton, South Africa., Chen T; Discovery Health, Sandton, South Africa., Bennett S; Medscheme, Cape Town, South Africa., Mametja S; Government Employees Medical Scheme, Pretoria, South Africa., Semenya M; Government Employees Medical Scheme, Pretoria, South Africa., Moultrie H; Centre for Tuberculosis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa., de Oliveira T; KwaZulu-Natal Research Innovation, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa., Lessells RJ; KwaZulu-Natal Research Innovation, School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa., Cohen C; School of Public Health, Faculty of Health Sciences, University of the Witwatersrand, Witwatersrand, South Africa; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa., Jassat W; National Institute for Communicable Diseases, Sandringham, South Africa., Groome M; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Witwatersrand, South Africa; Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Johannesburg, South Africa., Von Gottberg A; Department of Pathology, Cape Town, South Africa; School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Witwatersrand, South Africa; Centre for Respiratory Diseases and Meningitis, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa., Le Roux E; Hutchinson Center Research Institute of South Africa (HCRISA), Chris Hani Baragwanath Academic Hospital, Soweto, South Africa., Khuto K; Hutchinson Center Research Institute of South Africa (HCRISA), Chris Hani Baragwanath Academic Hospital, Soweto, South Africa., Barouch D; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Mahomed H; Metro Health Services, Western Cape Government Health, Cape Town, South Africa; Division of Health Systems and Public Health, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa., Wolmarans M; National Department of Health, Pretoria, South Africa., Rousseau P; National Department of Health, Pretoria, South Africa., Bradshaw D; South African Medical Research Council, Tygerberg, South Africa., Mulder M; South Africa Medical Research Council, Cape Town, South Africa., Opie J; University of Cape Town, Cape Town, South Africa; National Health Laboratory Service, Cape Town, South Africa., Louw V; Division of Clinical Haematology, Department of Medicine, Cape Town, South Africa; Groote Schuur Hospital, Cape Town, South Africa., Jacobson B; Faculty of Health Sciences, and Allergy and Immunology Unit, Cape Town, South Africa., Rowji P; Neurology Association of South Africa, The Southern African Society of Thrombosis and Haemostasis, Johannesburg, South Africa., Peter JG; Division of Allergy and Clinical Immunology, Cape Town, South Africa., Takalani A; Hutchinson Center Research Institute of South Africa (HCRISA), Chris Hani Baragwanath Academic Hospital, Soweto, South Africa., Odhiambo J; Hutchinson Center Research Institute of South Africa (HCRISA), Chris Hani Baragwanath Academic Hospital, Soweto, South Africa., Mayat F; Perinatal HIV Research Unit (PHRU), Chris Hani Baragwanath Academic Hospital, University of the Witwatersrand, Witwatersrand, South Africa., Takuva S; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Gray GE; South Africa Medical Research Council, Cape Town, South Africa. Electronic address: glenda.gray@mrc.ac.za.

Publikováno v: Lancet (London, England) [Lancet] 2022 Mar 19; Vol. 399 (10330), pp. 1141-1153.

Safety of Janssen Ad26.COV.S and Astra Zeneca AZD1222 COVID-19 Vaccines among Mobile Phone Users in Malawi: Findings from a National Mobile-Based Syndromic Surveillance Survey, July 2021 to December 2021.

Autor: Makonokaya, Lucky, Kapanda, Lester, Woelk, Godfrey B., Chauma-Mwale, Annie, Kalitera, Louiser Upile, Nkhoma, Harrid, Zimba, Suzgo, Chamanga, Rachel, Golowa, Cathy, Machekano, Rhoderick, Maphosa, Thulani

Publikováno v: International Journal of Environmental Research & Public Health; Dec2023, Vol. 20 Issue 23, p7123, 12p